Carfilnat Injection is used for the treatment of multiple myeloma (a type of blood cancer affecting plasma cells), specifically for adult patients whose disease has returned or no longer responds to previous treatments. It contains the active ingredient carfilzomib (60 mg per vial), which belongs to a class of medications called proteasome inhibitors.